Watchlist
MTW · The Manitowoc Company, Inc.
Last analysed ·
Against its published line
Nothing is through its line on this close.
How to read this
The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on 18 September 2026; a dot LEFT of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.
Current thesis
Manitowoc's crane-order recovery supports its re-rating if Q3 backlog holds at least $1,050.1 million and raised 2026 profit guidance survives. A weekly close below $18 invalidates the price thesis; the Q3 reporting date remains unconfirmed.
Kill line
A weekly close below $18 invalidates the crane-order re-rating; a secondary break is Q3 backlog below the $1,050.1 million Q2 mark or a reduction in the $150–170 million 2026 adjusted EBITDA guidance issued on 2026-08-06.
Pick status
Open commitment catalyst in 11dscored if the kill line above fires How this is scored →Latest analysis and events for MTW —
As of 8 September 2026, the latest FrontierPicks analysis for The Manitowoc Company, Inc. (MTW): Manitowoc's crane-order recovery supports its re-rating if Q3 backlog holds at least $1,050.1 million and raised 2026 profit guidance survives. A weekly close below $18 invalidates the price thesis; the Q3 reporting date remains unconfirmed.
Kill line: A weekly close below $18 invalidates the crane-order re-rating; a secondary break is Q3 backlog below the $1,050.1 million Q2 mark or a reduction in the $150–170 million 2026 adjusted EBITDA guidance issued on 2026-08-06.
Next dated event on file: — catalyst in 11d.
Current Thesis
Manitowoc's crane-order recovery supports the re-rating if third-quarter backlog holds at least $1,050.1 million and management maintains its raised 2026 profit guidance before a weekly close below $18 breaks the price thesis. Those tests come from the second-quarter disclosures of 2026-08-06 and 2026-08-07; the third-quarter reporting date remains unconfirmed.
The measured operating evidence remains orders of $708.7 million, up 56.1% year over year, and backlog of $1,050.1 million in the 2026-08-07 results materials. Management raised full-year adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) guidance to $150–170 million on 2026-08-06. The inference is that stronger orders can sustain the earnings recovery; one quarter is too small a sample to establish a durable cycle.
On the available price evidence, the narrative is accelerating — the adjusted close reached its 52-week high of $21.41 on 2026-09-04, with the shares up 79.3% over three months. That classification describes price momentum; expanding investor participation has not been established. A weekly close below $18 would invalidate the continuation case.
The concrete calendar change since the 2026-09-07 note is that the August construction-spending release can be dated to 2026-10-01 without an estimate marker. It supplies an industry-demand check before the still-unconfirmed third-quarter earnings date. US Census Bureau release schedule
Bullish and bearish views on The Manitowoc Company, Inc.
The model's bull view on The Manitowoc Company, Inc. (MTW), in brief: Orders exceeded quarterly deliveries. The 2026-08-07 second-quarter materials reported orders of $708.7 million, backlog of $1,050.1 million and a book-to-bill ratio of 1.2, meaning orders exceeded reported sales. A third-quarter ratio below 1.0 would contradict continued order… The bear view: Tariff refunds supported reported profit. Both cases follow in full.
Bull Case
- Orders exceeded quarterly deliveries. The 2026-08-07 second-quarter materials reported orders of $708.7 million, backlog of $1,050.1 million and a book-to-bill ratio of 1.2, meaning orders exceeded reported sales. A third-quarter ratio below 1.0 would contradict continued order replenishment.
- Management raised the earnings range. On 2026-08-06, Manitowoc raised 2026 adjusted EBITDA guidance to $150–170 million from $125–150 million and sales guidance to $2.300–2.400 billion from $2.250–2.350 billion. A subsequent reduction would undermine the earnings component of the re-rating.
- Leverage fell below management's threshold. The 2026-08-07 earnings slides reported net leverage of 2.6 times against management's stated 3.0-times target, with liquidity of $304 million. These are measured balance-sheet improvements, without establishing the direction of subsequent cash generation.
Bear Case
- Tariff refunds supported reported profit. The 2026-08-07 earnings slides attributed $12 million of second-quarter adjusted EBITDA to tariff refunds and embedded a $16 million net tariff benefit in the 2026 outlook. The profit improvement therefore cannot be attributed entirely to operating performance.
- Cash conversion remained incomplete. Second-quarter free cash flow was negative $6 million in the 2026-08-07 slides, while the 2026-08-06 full-year adjusted free-cash-flow outlook was $50–70 million. The quarterly and annual measures are differently labelled; they do not establish a directly comparable cash-conversion bridge. A reduction in the annual range would weaken the recovery case.
- Analyst targets lagged the market. Benzinga reported Barclays' $16 target on 2026-08-10 and Wells Fargo's $12 target on 2026-08-13, both with Underweight ratings. Both targets were below the market's supplied adjusted close of $21.41 on 2026-09-04; those dated opinions do not establish subsequent revisions or investor positioning.
Setup & Price Structure
The 2026-09-04 adjusted close of $21.41 matched the supplied 52-week high. The 14-day relative strength index (RSI) was 60.1, alongside a three-month price increase of 79.3%. These observations establish a strong trailing advance without establishing how much demand remains.
Benzinga's 2026-08-13 industrial-stock screen reported an RSI of 85.7 for Manitowoc. The later reading is lower, but the observations are too sparse to prove that a durable base formed or that crowding cleared. No moving-average value, trading-volume series or investor-flow measure is supplied for 2026-09-04, so distance above a rising average and participation breadth remain unmeasured.
The $18 weekly-close threshold remains the research invalidation published on 2026-09-07. The available price snapshot does not independently establish it as tested support. The market's 2026-09-04 high close of $21.41 is the reference for whether the advance extends; a weekly close below $18 ends the continuation thesis.
Catalyst Calendar (next 30 days)
- 2026-09-30 — Fiscal third-quarter end. This is the accounting cutoff identified in the 2026-09-07 coverage, not a scheduled public release of orders or backlog. The subsequent results supply the comparison with the second quarter's $1,050.1 million backlog.
- 2026-10-01 — August construction spending. The Census Bureau schedules the release for this date. Non-residential and manufacturing construction provide an industry-demand cross-check; declines would weaken the demand backdrop but would not by themselves establish a fall in Manitowoc orders. US Census Bureau release schedule
- ~2026-11-04, est. Third-quarter results. This remains the unconfirmed estimate in the 2026-09-07 coverage, outside the next 30 days. The thesis turns on reported backlog, order replenishment and whether management maintains the $150–170 million adjusted EBITDA outlook issued on 2026-08-06.
What Would Change Our Mind
Loss of the August–September re-rating would break the price case: a weekly close below $18 is the published condition, assessed against the same adjusted daily series that recorded $21.41 on 2026-09-04. The condition remains unchanged; the available evidence does not establish a replacement support level.
Operating confirmation requires third-quarter backlog at least equal to the $1,050.1 million second-quarter mark and maintenance of the 2026 adjusted EBITDA range of $150–170 million. Backlog below that mark, book-to-bill below 1.0 or a reduction in the guidance issued on 2026-08-06 would invalidate the corresponding recovery claim. A change to the estimated reporting date alone would not establish operating deterioration.
Correlation Notes
FrontierPicks' Cyclical industrials group moved from maturing on 2026-08-26 to accelerating on 2026-09-06. Its listed peers include AGCO, CNH, TITN, BWMN and RCMT. That is a dated editorial classification of the group, not a measured return correlation or proof of common investor flows.
No paired return series is supplied in this 2026-09-08 update, so a correlation coefficient cannot be stated. The group classification does not override Manitowoc's company-specific tests: a weekly close below $18 or a third-quarter failure to sustain the second-quarter backlog and raised guidance would break the case even if the broader group continued advancing.
Notes
- Reported EBITDA carries a tariff-refund benefit ($12M in Q2 2026, $16M net assumed in the FY26 guide) that is policy-dependent and separable from operating margin.
- Manitowoc is the petitioner in the US antidumping case on Japanese lattice-boom crawler cranes, so trade headlines hit both revenue relief and steel/component input costs.
- Crane orders are lumpy and backlog conversion is disclosed only quarterly, so single-quarter book-to-bill swings above 20% are normal for this name.
- Sell-side coverage is two contributing analysts on the S&P Global panel, so consensus EPS and target averages move violently on one firm's revision.
- Form 4 filings carry a two-business-day lag, so an absence of reported insider sales is a statement about the filing record, not about the current week.
- Market capitalisation was $772.09M on 2026-09-07, so single-day moves of 4-5% occur without company news.
Related · shared themes
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
ARCB
ArcBest Corporation
ArcBest’s cost-reduction rebound failed its published price condition at the 2026-09-18 weekly close of $128.73. Third-quarter results still test recurring savings and preservation of the second-quarter 90.8% adjusted Asset-Based operating ratio, but cannot undo that invalidation.
JBHT
J.B. Hunt Transport Services, Inc.
J.B. Hunt’s freight-recovery thesis was invalidated by the 2026-09-18 weekly close below $265. The estimated 2026-10-15 report tests whether intermodal pricing and profit growth can support a separate recovery case after September’s cost warning.
XPO
XPO, Inc.
XPO, Inc.'s shipment-and-margin thesis failed its price test when the 2026-09-18 weekly close of $174.25 breached $185. The 2026-10-29 results still test shipment growth and management's guidance for an adjusted less-than-truckload operating ratio below 81%.